Mylan-Budesonide AQ · DIN 02230648 · 100 mcg/Metered Dose · Nas Sp-165 Dose Pk
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Mylan-Budesonide AQ · DIN 02230648
Manufacturer: Mylan Pharmaceuticals ULC; listing date 1998-12-31
Health Canada: Marketed since 2010-06-24 · brand MYLAN-BUDESONIDE AQ · ATC R01AD05 BUDESONIDE · form Spray (metered-dose) · route Nasal · ingredients BUDESONIDE 100 MCG/ACT · company Mylan pharmaceuticals ulc · schedule Prescription
Mylan-Budesonide AQ: Formulary list price $12.74 per unit (the source does not state the unit; exact figure $12.7400). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02230648)
Source record
DIN 02230648: Mylan-Budesonide AQ
Raw flags: sec3=Y
Item: 520800032; group id 591; item number 1549; lccId None; manufacturer id MYL
Source form: Nas Sp-165 Dose Pk; strength: 100mcg/Metered Dose
Recorded listing: General benefit
Source prices (unrounded): $12.7400; ministry $12.7400
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230648
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=49895
Interchangeable products
Rhinocort Aqua · DIN 01974432 · not recorded
Shortage status: not checked (no credentials)